Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis
about
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.Disease-modifying therapies in relapsing-remitting multiple sclerosis.N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.Multiple sclerosis therapeutic pipeline: opportunities and challenges.Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database.
P2860
Q34090086-09F3796C-24CE-4508-A90E-75B18ACF12D3Q34122924-CED8687C-4263-44C5-9E1B-7FA1B883BB5AQ35756367-2CC64CA4-39BB-4D70-97FE-F48469249420Q37855722-AEC6FBD4-61B9-443E-9B45-E08F12F32A17Q38152977-2502E84A-95AB-42D6-867B-F47285BC87D1Q38449394-E954A92D-0FE5-4588-AAD5-F63CC06DD0DAQ39672574-B6FBECEC-0F7B-470C-8619-D0F625ECDF9CQ47814600-7FA09FDB-AFCE-4EC6-92E8-558DFE97FE88Q55086936-40D56623-3C14-4566-B886-5A38367181A9
P2860
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risks vs benefits of glatirame ...... emerge for multiple sclerosis
@ast
Risks vs benefits of glatirame ...... emerge for multiple sclerosis
@en
type
label
Risks vs benefits of glatirame ...... emerge for multiple sclerosis
@ast
Risks vs benefits of glatirame ...... emerge for multiple sclerosis
@en
prefLabel
Risks vs benefits of glatirame ...... emerge for multiple sclerosis
@ast
Risks vs benefits of glatirame ...... emerge for multiple sclerosis
@en
P2860
P356
P1476
Risks vs benefits of glatirame ...... emerge for multiple sclerosis
@en
P2093
Kenneth P Johnson
P2860
P304
P356
10.2147/TCRM.S6743
P577
2010-04-15T00:00:00Z